Healthcare Business

95992888

Why Lannett Is Running

Lannett Co. Inc. (NYSE: LCI) climbed high on Thursday despite the broad markets taking a slight downturn toward the end of the session. One key analyst explained why. The company ...
Read Full Story »
Money background. Close-up.

Q1 Revenue Lifts Medtronic Over Low Earnings Bar

Medtronic PLC (NYSE: MDT) reported its fiscal first-quarter financial results before the markets opened on Thursday. The company said it had $1.02 in earnings per share (EPS) on $7.3 billion ...
Read Full Story »
152498601

Tesaro Rises on Positive FDA Results

Tesaro Inc. (NASDAQ: TSRO) shares reacted positively in the market Wednesday as positive study results have been released surrounding its lead product. The company announced that the U.S. Food and ...
Read Full Story »
dollar

What to Expect From Medtronic Earnings

Medtronic PLC (NYSE: MDT) is scheduled to report its fiscal first-quarter financial results on Thursday after the markets close. The consensus estimates from Thomson Reuters call for $1.01 in earnings ...
Read Full Story »
145922793

Heartware Moves to Acquire Valtech Cardio

HeartWare International Inc. (NASDAQ: HTWR) is looking to continue its strong performance in 2015, and one of the better options that the company sees for growth is an acquisition. The ...
Read Full Story »
95992888

Is the Move in Trevena Sustainable?

Trevena Inc. (NASDAQ: TRVN) saw its shares continue to climb during Tuesday’s session on news of a positive Phase 2 trial. Despite this colossal jump, investors should be asking themselves ...
Read Full Story »
generic drugs

Cortendo Prepares for IPO

Cortendo PLC has filed an F-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). No terms were given in the filing, but the ...
Read Full Story »
Prescription drugs

PharMEDium Files for IPO

PharMEDium Healthcare Holdings Inc. has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). No terms were given in the filing, ...
Read Full Story »
IPO

American Renal Associates Prepares for IPO

American Renal Associates Holdings Inc. has filed an S-1 form with the Securities and Exchange Commission (SEC) for its initial public offering (IPO). No terms were given in the filing, ...
Read Full Story »
DNA

NovoCure Gears Up for IPO

NovoCure Ltd. Has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). No terms were given in the filing, but the ...
Read Full Story »
IPO

Sancilio Pharma Files for IPO

Sancilio Pharmaceuticals Co. Inc. has filed an S-1 form with the Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No terms were given in the filing, but ...
Read Full Story »
software

What Illumina Gets With GenoLogics Life Science Software

Tuesday morning, Illumina Inc. (NASDAQ: ILMN) announced the completion of its acquisition of GenoLogics Life Science Software. Illumina President Francis deSouza said: We look forward to working with the talented ...
Read Full Story »
biotech

Trevena Soars on Positive Phase 2 Results

Trevena Inc. (NASDAQ: TRVN) watched its shares soar in Monday’s after-hours session on news of a positive Phase 2 trial. The company announced positive data from its randomized, double-blind, placebo- ...
Read Full Story »
health care

Is the BioLife Move Sustainable?

BioLife Solutions Inc. (NASDAQ: BLFS) was up solidly in Monday’s trading session on positive results from a Phase 3 study. The company announced that its customer TiGenix NV recently disclosed ...
Read Full Story »
thumbs up

Why Recent IPO Aimmune Therapeutics Could Rise 50% to 100%

Aimmune Therapeutics Inc. (NASDAQ: AIMT) announced the closing of its initial public offering of nearly 11.5 million shares at the price of $16 per share. With the closing of the ...
Read Full Story »